Givinostat Hydrochloride Patent Expiration
Givinostat Hydrochloride was first introduced by Italfarmaco Spa
Givinostat Hydrochloride Patents
Given below is the list of patents protecting Givinostat Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Duvyzat | US10688047 | Physically and chemically stable oral suspensions of givinostat | Oct 28, 2036 | Italfarmaco Spa |
| Duvyzat | US9421184 | Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy | Feb 03, 2032 | Italfarmaco Spa |
| Duvyzat | US9867799 | Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy | Feb 03, 2032 | Italfarmaco Spa |
| Duvyzat | US7329689 | Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester | Jan 15, 2025 | Italfarmaco Spa |
Givinostat Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List